ArticleJournal of the National Cancer Institute2014

Re: Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer.

Lisa M Hess et al.PubMed ↗Publisher ↗

No numbers read from the abstract.